Investing.com - Rubicon Research Limited, a pharmaceutical formulations company, has filed an addendum to its Draft Red Herring Prospectus (DRHP) with SEBI, updating its financial information for FY25 ...

Intel Corporation, NVIDIA Corporation, DR Horton Inc, Lennar Corporation. Read 's Market Analysis on Investing.com ...

(Reuters) -More than 750 U.S. Department of Health and Human Services staff have urged Secretary Robert F. Kennedy Jr. to ...

Investing.com -- Small caps and homebuilders are the most at risk if the Federal Reserve strikes a hawkish tone at Jackson Hole, according to Barclays. Barclays’ economists maintain a contrarian ...

Investing.com -- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stock surged 23% after the FDA lifted a clinical hold on the company’s pivotal Phase 2 trial of RP-A501 for the treatment of Danon disease.

Investing.com -- The Swedish government on Wednesday maintained its GDP growth forecast for 2025 and raised its projection for 2026. The government kept its 2025 growth forecast at 0.9%, unchanged ...

Target (NYSE: TGT) stock slumped 10% after the discounter appointed Michael Fiddelke, the company’s current Chief Operating ...

Rolls-Royce continues to outperform after a sharp turnaround. Its civil aerospace and power systems divisions delivered ...

Investing.com -- The TJX Companies (NYSE: TJX ), Inc. reported second-quarter earnings that exceeded analyst expectations, ...

The FDA determined it could not approve the Premarket Approval application for VenoValve, a surgical replacement venous valve designed to treat severe deep chronic venous insufficiency, in its current ...

Investing.com -- Bank of America Securities (BofA) lifted its rating on Snowflake (NYSE: SNOW) to Buy from Neutral and raised ...

European shares remain much cheaper than their U.S. counterparts. Trading at 14.3 times 12-month forward earnings, the STOXX ...